High apoB/apoA-I ratio (≥ 0.82) recorded before coronary angiography in NSTE-ACS patients calls for proper readiness (pharmacological and technical) due to high probability of tackling a complex multi-vessel disease. The gene discussed is APOB; the disease is glycogen storage disease VI.